AML with Recurrent Genetic Abnormalities — knowledge graph

Loading the knowledge graph…

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
AML with Recurrent Genetic Abnormalities investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 64show all (up to 200)
→ investigated in trials for	Cytarabinesmall molecule 52 trials (6 active) · roll-up of the cancer and its descendants	—	—	AML with Recurrent Genetic Abnormalities	52	Observed	clinicaltrials	graph →
→ investigated in trials for	Fludarabine

AML with Recurrent Genetic Abnormalities studied in …STUDIED_INderived183 of 183show fewer
→ studied in	NCT00801489Phase 2 · recruiting Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 183 trials mapped (11 active)	—	—	Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT07566585Phase 1 · withdrawn Dose Finding Study to Evaluate the Safety of BSB-2002 in Relapsed or Refractory Acute Myeloid Leukemia (AML) Patients With NPM1 Mutation · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Acute Myeloid Leukemia with NPM1 Mutation	1	Observed	clinicaltrials	graph →
→ studied in	NCT05886049Phase 1 · recruiting A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease · condition mapped ONTOLOGY_EXACT · 183 trials mapped (11 active)	—	—	Acute Myeloid Leukemia with NPM1 Mutation	1	Observed	clinicaltrials	graph →
→ studied in	NCT06001788Phase 1 · recruiting Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Acute Myeloid Leukemia with NPM1 Mutation	1	Observed	clinicaltrials	graph →
→ studied in	NCT03147612Phase 2 · active not recruiting Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia · condition mapped ONTOLOGY_EXACT · 183 trials mapped (11 active)	—	—	Acute Myeloid Leukemia with BCR-ABL1	1	Observed	clinicaltrials	graph →
→ studied in	NCT02071901Phase 2 · completed Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00093470Phase 3 · completed Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission · condition mapped ONTOLOGY_EXACT · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00658814Phase 2 · active not recruiting Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT02094794Phase 2 · active not recruiting Total Marrow and Lymphoid Irradiation and Chemotherapy Before DSCT in Treating Patients With High-Risk ALL or AML · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00085124Phase 3 · completed Daunorubicin Hydrochloride, Cytarabine and Oblimersen Sodium in Treating Patients With Previously Untreated Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT06222580Phase 1 · recruiting SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation · condition mapped ONTOLOGY_EXACT · 183 trials mapped (11 active)	—	—	Acute Myeloid Leukemia with NPM1 Mutation	1	Observed	clinicaltrials	graph →
→ studied in	NCT01627041Phase 2 · active not recruiting Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A	1	Observed	clinicaltrials	graph →
→ studied in	NCT01384513Phase 2 · completed A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT05735184Phase 1 · recruiting A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Acute Myeloid Leukemia with NPM1 Mutation	1	Observed	clinicaltrials	graph →
→ studied in	NCT01199562active not recruiting Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01869114Phase 2 · completed Sirolimus and Azacitidine in Treating Patients With High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia That is Recurrent or Not Eligible for Intensive Chemotherapy · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01139970Phase 1 · completed Veliparib and Temozolomide in Treating Patients With Acute Leukemia · condition mapped ONTOLOGY_EXACT · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01760655Phase 2 · completed Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 183 trials mapped (11 active)	—	—	Acute Myeloid Leukemia with inv(3)(q21.3;q26.2); GATA2, MECOM	1	Observed	clinicaltrials	graph →
→ studied in	NCT07028073Phase 1/Phase 2 · recruiting A New Treatment of Newly Diagnosed KIT Mutation CBF-Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Acute Myeloid Leukemia with t(8;21)(q22;q22.1); RUNX1-RUNX1T1	1	Observed	clinicaltrials	graph →
→ studied in	NCT01822015early Phase 1 · completed Sirolimus, Idarubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00588991Phase 1 · completed Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders · condition mapped ONTOLOGY_EXACT · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT02085408Phase 3 · completed Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01588015Phase 1 · completed Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00540995Phase 1/Phase 2 · terminated Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01523223Phase 1 · completed Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT03701295Phase 1/Phase 2 · completed Pinometostat and Azacitidine in Treating Patients With Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia With 11q23 Rearrangement · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A	1	Observed	clinicaltrials	graph →
→ studied in	NCT05504408unknown Observational Study for the Evaluation of Incidence of Systemic Mastocytosis in t(8;21) Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Acute Myeloid Leukemia with t(8;21)(q22;q22.1); RUNX1-RUNX1T1	1	Observed	clinicaltrials	graph →
→ studied in	NCT02122081Phase 1 · completed Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT02299518Phase 1 · completed Selinexor and Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01238211Phase 2 · completed Combination Chemotherapy and Dasatinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01028716Phase 2 · terminated Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Acute Myeloid Leukemia with inv(3)(q21.3;q26.2); GATA2, MECOM	1	Observed	clinicaltrials	graph →
→ studied in	NCT00119366Phase 2 · terminated Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00866918Phase 3 · completed Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Childhood Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA	1	Observed	clinicaltrials	graph →
→ studied in	NCT04689815Phase 2 · unknown Oral Arsenic Trioxide for NPM1-mutated AML · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Acute Myeloid Leukemia with NPM1 Mutation	1	Observed	clinicaltrials	graph →
→ studied in	NCT01555268Phase 1 · completed Trebananib With or Without Low-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01168219Phase 2 · completed Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01253070Phase 2 · completed Sorafenib Tosylate and Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 183 trials mapped (11 active)	—	—	Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01550185Phase 1 · terminated Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01005277completed Study of Biomarkers in DNA Samples From Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01876953Phase 1/Phase 2 · terminated Dasatinib, Cytarabine, and Idarubicin in Treating Patients With High-Risk Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00352365Phase 2 · completed Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT02105116NA · terminated AML Therapy With Irradiated Allogeneic Cells · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT02144675Phase 2 · completed Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00860574Phase 2 · completed Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00536601NA · completed High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01307579Phase 3 · completed Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00489203Phase 2 · completed Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01445080Phase 1/Phase 2 · completed Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Childhood Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA	1	Observed	clinicaltrials	graph →
→ studied in	NCT01246622Phase 1 · completed Lenalidomide and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01869777NA · completed Bioelectrical Impedance Measurement for Predicting Treatment Outcome in Patients With Newly Diagnosed Acute Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01235572Phase 2 · completed Early Discharge and Outpatients Care in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Previously Treated With Intensive Chemotherapy · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01839240Phase 1 · completed Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT02316964Phase 1 · completed Decitabine, Donor Natural Killer Cells, and Aldesleukin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00040846Phase 2 · completed Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00045435Phase 2 · completed Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00089011Phase 2 · completed Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00014235NA · completed Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00078858Phase 1/Phase 2 · completed Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01664897Phase 2 · completed Erlotinib Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01707004Phase 2 · completed Decitabine and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00008177Phase 1 · completed Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00856388NA · completed Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00105001Phase 2 · completed Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A	1	Observed	clinicaltrials	graph →
→ studied in	NCT01529827Phase 2 · completed Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00005799NA · completed Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01519596NA · completed Symptom-Adapted Physical Activity Intervention in Minimizing Physical Function Decline in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01839916Phase 2 · completed Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01159067Phase 2 · terminated Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00895934Phase 1/Phase 2 · completed Vorinostat, Azacitidine, and Gemtuzumab Ozogamicin for Older Patients With Relapsed or Refractory AML · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT02030405Phase 2 · terminated Ixazomib (MLN9708) in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01175785Phase 2 · completed Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01031368Phase 1 · completed Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00416598Phase 2 · completed Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01849276Phase 1 · terminated Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01093586Phase 2 · completed Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT02019069Phase 2 · completed CPX-351 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01904643Phase 1 · terminated Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01273766Phase 2 · completed Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00039091Phase 1 · terminated Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung Cancer · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01253447Phase 2 · completed AKT Inhibitor MK-2206 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00795002Phase 2 · completed Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01789255Phase 2 · completed Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01872819NA · completed Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01768897Phase 1 · completed CPI-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01548911Phase 2 · withdrawn Gemtuzumab Ozogamicin in Treating Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00666588Phase 2 · completed Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01835288Phase 2 · withdrawn Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00357032Phase 2 · completed PXD101 in Treating Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01801046Phase 1 · terminated Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01798901Phase 1 · completed AR-42 and Decitabine in Treating Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00602225Phase 1/Phase 2 · completed Clofarabine, Cytarabine, and G-CSF in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01842139Phase 1 · completed Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete Remission · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01869803approved for marketing Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Promyelocytic Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01564277Phase 2 · terminated Rasburicase and Allopurinol in Treating Patients With Hematologic Malignancies · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00445744NA · completed Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT02049801Phase 1 · terminated MEK Inhibitor MEK162, Idarubicin, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01831232NA · completed Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01101880Phase 2 · completed Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Advanced Myeloproliferative Neoplasm · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01254578Phase 1 · completed Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers · condition mapped ONTOLOGY_EXACT · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00005940Phase 2 · completed Radiolabeled BC8 Antibody, Busulfan, Cyclophosphamide Followed by Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia in First Remission · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01141725Phase 1/Phase 2 · completed Bendamustine and Idarubicin in Treating Older Patients With Previously Untreated AML or MDS · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01349972Phase 2 · completed Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride or Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00462605Phase 2 · completed MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00839982Phase 1/Phase 2 · completed Clofarabine and Cytarabine in Treating Older Patients With AML or High-Risk MDS · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01342887Phase 1/Phase 2 · terminated Cyclosporine, Pravastatin Sodium, Etoposide, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01076270NA · terminated Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00003875Phase 2 · completed Busulfan and Etoposide Followed by Peripheral Blood Stem Cell Transplant and Low-Dose Aldesleukin in Treating Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00673153Phase 2 · terminated Vorinostat and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00112593NA · completed Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01083706Phase 2 · completed Azacitidine in Treating Patients With Relapsed Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00795769Phase 2 · completed Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00049504Phase 2 · completed Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00863434Phase 2 · terminated Clofarabine and Cytarabine in Treating Patients With Acute Myeloid Leukemia With Minimal Residual Disease · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01820624Phase 1 · completed Lithium Carbonate and Tretinoin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01465386Phase 2 · terminated Bortezomib in Treating Patients With High-Risk Acute Myeloid Leukemia in Remission · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01607645Phase 2 · terminated Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory AML and MDS · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00052520Phase 1/Phase 2 · completed Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00408681NA · completed Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00093743Phase 1 · completed Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated Donor Stem Cell Transplant in Treating Patients With Fanconi Anemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00052598Phase 1/Phase 2 · terminated Therapeutic Allogeneic Lymphocytes and Aldesleukin in Treating Patients With High-Risk or Recurrent Myeloid Leukemia After Undergoing Donor Stem Cell Transplant · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00475150Phase 2 · completed Cediranib Maleate in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00313586Phase 2 · completed Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01870596Phase 2 · completed Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01652014Phase 2 · withdrawn Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01174888Phase 1 · completed Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00492401Phase 2 · completed Decitabine in Treating Patients With Previously Untreated Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT02029417Phase 2 · terminated Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01056614Phase 2 · completed Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Malignancies · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00039117Phase 1 · completed Oblimersen, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00062075Phase 2 · completed Romidepsin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00459212Phase 1 · completed GTI-2040 in Treating Patients With Relapsed, Refractory, or High-Risk Acute Leukemia, High-Grade Myelodysplastic Syndromes, or Refractory or Blastic Phase Chronic Myelogenous Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01260714Phase 1 · terminated Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01127009Phase 1 · completed Bortezomib, Mitoxantrone, Etoposide, and Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00407966Phase 2 · completed Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00634244Phase 2 · completed Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01521936Phase 2 · terminated Cholecalciferol in Treating Patients With Acute Myeloid Leukemia Undergoing Intensive Induction Chemotherapy · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00217646Phase 1 · completed Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia · condition mapped ONTOLOGY_EXACT · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00383474Phase 1 · completed Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Phase · condition mapped ONTOLOGY_EXACT · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01361464Phase 2 · completed Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00343798Phase 1 · completed A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00351975Phase 1 · completed Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases · condition mapped ONTOLOGY_EXACT · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01132586Phase 1 · completed Lenalidomide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00703300Phase 1 · completed Decitabine and Bortezomib in Treating Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00322101Phase 3 · completed Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00602771Phase 2 · completed Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00742625Phase 1/Phase 2 · completed Bortezomib, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00275080Phase 1 · completed Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00387426Phase 2 · terminated Sunitinib in Treating Patients With Idiopathic Myelofibrosis · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00096122Phase 1/Phase 2 · completed Idarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00305773Phase 2 · completed Vorinostat in Treating Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01233921NA · completed Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00890747Phase 1 · completed Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00049582Phase 1 · terminated Decitabine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00079378Phase 1 · completed Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00098423Phase 1 · completed Tanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00301769Phase 1 · terminated SJG-136 in Treating Patients With Relapsed or Refractory Acute Leukemia, Myelodysplastic Syndromes, Blastic Phase Chronic Myelogenous Leukemia, or Chronic Lymphocytic Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00301938Phase 1 · completed 7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic Syndromes · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00331513Phase 1 · completed Vorinostat and Idarubicin in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndromes · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00470197Phase 1 · completed Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01159301Phase 1 · terminated Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00003190Phase 3 · completed Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00006363Phase 3 · completed Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00070551Phase 1 · completed GTI-2040 and High-Dose Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00101231Phase 1 · terminated Flavopiridol in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00103272Phase 1 · terminated 17-N-Allylamino-17-Demethoxygeldanamycin and Bortezomib in Treating Patients With Relapsed or Refractory Hematologic Cancer · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00357305Phase 1 · completed Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00060372Phase 1 · completed Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00027872Phase 2 · completed Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00095797Phase 1 · completed XK469R in Treating Patients With Refractory Hematologic Cancer · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00101296Phase 1 · completed Tipifarnib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00077181Phase 1 · completed 3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00084916Phase 2 · completed CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00087204Phase 1 · completed Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00093418Phase 2 · completed S0432 Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00098826Phase 1 · completed SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00012376Phase 1 · completed Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00045396Phase 2 · completed A Phase II Study Of The Farnesyltransferase Inhibitor ZANESTRA (R115777, NSC #702818, IND #58,359) In Complete Remission Following Induction And/Or Consolidation Chemotherapy In Adults With Poor-Risk Acute Myelogenous Leukemia (AML) And High-Risk Myelodysplasia (MDS) · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00112853Phase 1 · completed Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00131989Phase 1 · completed Sorafenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00357708Phase 1 · completed Vorinostat and Decitabine in Treating Patients With Relapsed, Refractory, or Poor-Prognosis Hematologic Cancer or Other Diseases · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01558778NA · withdrawn Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT00799461Phase 3 · completed Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →
→ studied in	NCT01177371Phase 2 · completed High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma · condition mapped ALIAS · 183 trials mapped (11 active)	—	—	Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11	1	Observed	clinicaltrials	graph →

AML with Recurrent Genetic Abnormalities studied in …STUDIED_INderived183 of 183show fewer

→ studied in

NCT00801489Phase 2 · recruiting

Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 183 trials mapped (11 active)

—

Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11

Observed

Radial view

Every edge, grouped by relationship

Strongest chains